Biological functions
Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
---|---|---|---|---|---|---|---|---|---|---|
BP | GO:0070542 | response to fatty acid | 31/3771 | 86/18670 | 0.0004624 | 0.012 | 0.009413 | 31 | RABC53 | |
BP | GO:0048638 | regulation of developmental growth | 96/3771 | 347/18670 | 0.000463 | 0.012 | 0.009413 | 96 | RABC53 | |
BP | GO:0006066 | alcohol metabolic process | 100/3771 | 364/18670 | 0.0004663 | 0.01204 | 0.009441 | 100 | RABC53 | |
BP | GO:0014706 | striated muscle tissue development | 106/3771 | 390/18670 | 0.0004894 | 0.01259 | 0.009869 | 106 | RABC53 | |
BP | GO:0030641 | regulation of cellular pH | 32/3771 | 90/18670 | 0.0004991 | 0.01274 | 0.009993 | 32 | RABC53 | |
BP | GO:0051452 | intracellular pH reduction | 21/3771 | 51/18670 | 0.0004995 | 0.01274 | 0.009993 | 21 | RABC53 | |
BP | GO:0007009 | plasma membrane organization | 36/3771 | 105/18670 | 0.0005127 | 0.01303 | 0.01021 | 36 | RABC53 | |
BP | GO:0055081 | anion homeostasis | 23/3771 | 58/18670 | 0.0005242 | 0.01327 | 0.0104 | 23 | RABC53 | |
BP | GO:0051289 | protein homotetramerization | 33/3771 | 94/18670 | 0.0005341 | 0.01346 | 0.01056 | 33 | RABC53 | |
BP | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 89/3771 | 319/18670 | 0.0005448 | 0.01368 | 0.01073 | 89 | RABC53 | |
BP | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation | 20/3771 | 48/18670 | 0.0005622 | 0.01401 | 0.01098 | 20 | RABC53 | |
BP | GO:0035272 | exocrine system development | 20/3771 | 48/18670 | 0.0005622 | 0.01401 | 0.01098 | 20 | RABC53 | |
BP | GO:0001837 | epithelial to mesenchymal transition | 45/3771 | 140/18670 | 0.0005679 | 0.01404 | 0.01101 | 45 | RABC53 | |
BP | GO:0060078 | regulation of postsynaptic membrane potential | 45/3771 | 140/18670 | 0.0005679 | 0.01404 | 0.01101 | 45 | RABC53 | |
BP | GO:0060411 | cardiac septum morphogenesis | 28/3771 | 76/18670 | 0.0005712 | 0.01407 | 0.01103 | 28 | RABC53 | |
BP | GO:0042698 | ovulation cycle | 26/3771 | 69/18670 | 0.0005958 | 0.0146 | 0.01144 | 26 | RABC53 | |
BP | GO:0003229 | ventricular cardiac muscle tissue development | 22/3771 | 55/18670 | 0.0005978 | 0.0146 | 0.01144 | 22 | RABC53 | |
BP | GO:0045216 | cell-cell junction organization | 49/3771 | 156/18670 | 0.0005996 | 0.0146 | 0.01144 | 49 | RABC53 | |
BP | GO:1903305 | regulation of regulated secretory pathway | 50/3771 | 160/18670 | 0.0006045 | 0.01461 | 0.01146 | 50 | RABC53 | |
BP | GO:0055025 | positive regulation of cardiac muscle tissue development | 24/3771 | 62/18670 | 0.0006067 | 0.01461 | 0.01146 | 24 | RABC53 | |
BP | GO:0006633 | fatty acid biosynthetic process | 51/3771 | 164/18670 | 0.0006084 | 0.01461 | 0.01146 | 51 | RABC53 | |
BP | GO:0043409 | negative regulation of MAPK cascade | 56/3771 | 184/18670 | 0.0006136 | 0.01461 | 0.01146 | 56 | RABC53 | |
BP | GO:0060317 | cardiac epithelial to mesenchymal transition | 15/3771 | 32/18670 | 0.000619 | 0.01461 | 0.01146 | 15 | RABC53 | |
BP | GO:0006069 | ethanol oxidation | 8/3771 | 12/18670 | 0.0006208 | 0.01461 | 0.01146 | 8 | RABC53 | |
BP | GO:0016554 | cytidine to uridine editing | 8/3771 | 12/18670 | 0.0006208 | 0.01461 | 0.01146 | 8 | RABC53 | |
BP | GO:0060391 | positive regulation of SMAD protein signal transduction | 8/3771 | 12/18670 | 0.0006208 | 0.01461 | 0.01146 | 8 | RABC53 | |
BP | GO:0060670 | branching involved in labyrinthine layer morphogenesis | 8/3771 | 12/18670 | 0.0006208 | 0.01461 | 0.01146 | 8 | RABC53 | |
BP | GO:0002456 | T cell mediated immunity | 36/3771 | 106/18670 | 0.0006275 | 0.01471 | 0.01154 | 36 | RABC53 | |
BP | GO:0048738 | cardiac muscle tissue development | 68/3771 | 233/18670 | 0.0006373 | 0.01489 | 0.01167 | 68 | RABC53 | |
BP | GO:0051589 | negative regulation of neurotransmitter transport | 12/3771 | 23/18670 | 0.0006509 | 0.01515 | 0.01188 | 12 | RABC53 |